FDA approves Xanodyne's Lysteda

FDA approved an NDA from Xanodyne Pharmaceuticals Inc. (Newport, Ky.) for Lysteda tranexamic acid ( XP12B) to treat menorrhagia (heavy menstrual bleeding). Lysteda is a modified-release formulation of...